An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

BACKGROUND: This study was designed to evaluate the occurrence and severity of ocular hyperemia in subjects with elevated intraocular pressure (IOP) due to primary open angle glaucoma (POAG) or ocular hypertension (OHT) following treatment with bimatoprost 0.01% in a real-world clinical setting. MET...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Crichton, Andrew C, Discepola, Marino, Hutnik, Cindy ML, Yan, David B
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2012
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3529655/
https://ncbi.nlm.nih.gov/pubmed/23269858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S35394
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak